Skip to main content

Radioimmunotherapy with Iodine 131-Labelled Antibodies in Ovarian, Colonic and Brain Tumours

  • Conference paper
Cancer Therapy
  • 76 Accesses

Abstract

Radiolabeled monoclonal antibodies have been shown to react preferentially to neoplastic cells and offer new approaches for targeted cancer treatment [1]. Monoclonal antibody technology [2] enables an antibody-producing lymphocyte to be fused with a cultured myeloma cell, thus producing a hybridoma that secretes a specific monoclonal antibody. It is now possible to manufacture large quantities of immunoglobulins with unique specificity. Monoclonal antibodies have been raised against tumor-associated antigens found in many types of cancer such as breast, lung, colonic, ovarian and bone cancer, as well as glioma, melanoma etc. Great effort has been directed towards the use of monoclonal antibodies to target potent cytotoxic or biologically active agents. Radiolabeled monoclonal antibodies have been utilised in patients for tumour localisation by external body scintigraphy, and encouraging clinical results have been reported by many workers [3–6]. Other potential uses of monoclonal antibodies include the delivery of chemotherapy [7], toxins [8] or radionuclides [9–13] to specifically destroy tumour cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Epenetos AA, Britton KE, Mather S, Shepherd J, Geanovska M, Taylor-Papadimitriou J, Nimmon CC, Durbin H, Hawkins LR, Malpas JS, Bodmer WF (1982) Targetting of Iodine 123-labelled tumour associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet 2: 999–1005

    Article  PubMed  CAS  Google Scholar 

  2. Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497

    Article  PubMed  Google Scholar 

  3. Mach J-P, Buchegger F, Forni M, Ritschard J, Berche C, Lumbroso JD, Schreyer M, Girardet C, Accola R, Carrel S (1981) Use of radiolabeled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunol Today 2: 239–249

    Article  Google Scholar 

  4. Farrands PA, Perkins AC, Pimm MV, Hardy JD, Embleton MJ, Baldwin RW, Hardcastle JD (1982) Radioimmunodetection of human colorectal cancer by an antitumour monoclonal antibody. Lancet 2: 397–400

    Article  PubMed  CAS  Google Scholar 

  5. Larson SM, Brown JP, Wright PW, Carrasquillo JA, Hellstrom I, Hellstrom KE (1983) Imag¬ing of melanomas with 1131-labelled monoclonal antibodies. J Nucl Med 23: 123–129

    Google Scholar 

  6. Buraggi GL, Callegaro L, Mariani G, Turrin A, Caseinelli N, Attili A, Bombardiert E, Terno G, Plassio G, Dovis M (1985) Imaging with 131I-labelled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: Efficacy of whole immunoglobulin and its F(ab’)2 fragments. Cancer Res 45: 3378–3387

    PubMed  CAS  Google Scholar 

  7. Baldwin RW, Pimm V (1983) Antitumour monoclonal antibodies for radioimmunodetection of tumours and drug targetting. Cancer Metastasis Rev 2: 89–106

    Article  PubMed  CAS  Google Scholar 

  8. Thorpe RE, Ross WC (1982) The preparation and cytotoxic properties of antibody-toxin conjugates. Immunol Rev 62: 119

    Article  PubMed  CAS  Google Scholar 

  9. Order SE, Klein JL, Ettinger D, Alderson P, Siegelman S, Leichner P (1980) Use of isotopic immunoglobulin in therapy. Cancer Res 40: 3001

    PubMed  CAS  Google Scholar 

  10. Epenetos AA, Courtenay-Luck N, Hainan KE, Hooker G, Hughes JMB, Krauz T, Lambert J, Lavender JP, MacGregor WG, McKenzie CG, Munro A, Myers MJ, Orr JS, Pearse EE, Snook D, Webb B, Burcell J, Durbin H, Kemshead J, Taylor-Papadimitriou J (1984) Antibody guided irradiation of malignant lesions. Lancet 30: 1441–1443

    Google Scholar 

  11. Carrasquilo JA, Krohn KA, Beaumier P, McGuffin RW, Brown JP, Hellstrom E, Hellstrom I, Larson SM (1984) Diagnosis of and therapy for solid tumour with radiolabeled antibodies and immune fragments. Cancer Treat Rep 68: 371–378

    Google Scholar 

  12. Epenetos AA, Courtenay-Luck N, Pickering D, Hooker G, Durbin H, Lavender JP, McKenzie CG (1985) Antibody-guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. Br Med J 290: 1463–1466

    Article  CAS  Google Scholar 

  13. Epenetos AA, Munro AJ, Stewart S, Rampling R, Lambert HE, McKenzie CG, Soutter P, Rahemtulla A, Hooker G, Sivolapenko GB, Snook D, Courtenay-Luck N, Dhokia B, Krauz T, Taylor-Papadimitriou J, Durbin H, Bodmer WF (1987) Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies. J Clin Oncol 5: 1890–1899

    PubMed  CAS  Google Scholar 

  14. Kalofonos HP, Epenetos AA (1987) Antibody-guided diagnosis and therapy of patients with breast cancer. In: Ceriani RL (ed) Immunological approaches to the diagnosis and therapy of breast cancer. Plenum, New York, pp 245–257

    Chapter  Google Scholar 

  15. Wilson CB, Epenetos AA (1987) Use of monoclonal antibodies for diagnosis and treatment of liver tumours. Bailliere’s Clinical Gastroenterology 1 (1): 115–130

    Article  CAS  Google Scholar 

  16. Arklie J, Taylor-Papadimitriou J, Bodmer WF, Egan M, Millis R (1981) Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer 28: 23–29

    Article  PubMed  CAS  Google Scholar 

  17. Burcell J, Durbin H, Taylor-Papadimitriou J (1983) Complexity of expression on antigenic determinants recognised by monoclonal antibodies HMFG1 and HMFG2 in normal and malignant tissue. J Immunol 131: 508–513

    Google Scholar 

  18. Epenetos AA, Nimmon CC, Arklie J, Elliot AT, Hawkins LA, Knowles RW, Britton KE, Bodmere WF (1982) Radioimmuno-diagnosis of human cancer in an animal model using labelled tumour associated monoclonal antibodies. Br J Cancer 46: 1–8

    Article  PubMed  CAS  Google Scholar 

  19. Travers P, Bodmer WF (1984) Preparation and characterization of monoclonal antibodies against placental alkaline phosphatase and other human trophoblast-associated determinants. Int J Cancer 33: 633–641

    Article  PubMed  CAS  Google Scholar 

  20. Waterfield MD, Mayes ELV, Stroonbard P, Bennet PL, Young G, Goodfellow PN, Banting GS, Ozone B (1982) A monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochem 20: 148–161

    Article  Google Scholar 

  21. Bosslet K, Lüben G, Schwarz A, Hundt E, Harthus HP, Seiler TR, Muhrer C, Klöppel G, Kayser K, Sedlacek HH (1985) Immunohistochemical localisation and molecular characteris-tics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen ( CEA ). Int J Cancer 36: 75

    Google Scholar 

  22. Leichner PK, Klein JL, Garrison JB, Jenkins RE, Nickoloff EL (1981) Dosimetry of 1131-labelled anti-ferritin in hepatoma: a model for radio-immunoglobulin dosimetry. Int J Rad On Biol Phys 7: 323–333

    Article  CAS  Google Scholar 

  23. Larson SM, Carrasquillo JA, McGuffin RW, Kohn KA, Ferens JM, Hill LD, Beaumier PL, Reynolds JC, Hellstrom KE, Hellstrom I (1985) Use of 131I-labelled murine Fab against a high molecular weight antigen of human melanoma. Preliminary experience. Radiology 155: 487–492

    Google Scholar 

  24. Fraker PJ, Speck JC (1978) Protein and cell membrane iodination with a sparingly soluble chloramine 1,3,4,6,tetrachloro-5,6-diphenyl-glycoril. Biochem Biophys Res Commun 80: 849–854

    Article  PubMed  CAS  Google Scholar 

  25. Hnatowich DJ, Layne WW, Childs RL (1983) Radioactive labeling of antibody: a simple and efficient method. Science 220: 613–615

    Article  PubMed  CAS  Google Scholar 

  26. Hnatowich DJ, Virzi F, Doherty PW (1985) DTPA-coupled antibodies labelled with yttrium 90. J Nucl Med 5: 503–509

    Google Scholar 

  27. Snyder WS, Ford MR, Warner GG (1978) Estimates of specific absorbed fractions for photon sources uniformly distributed in various organs of a heterogeneous phantom. Medical International Radiation Dose (MIRD) pamphlet 5. Society of Nuclear Medicine, New York, pp 55–67

    Google Scholar 

  28. Myers MJ, Lavender JP, de Oliveira JB (1981) A simplified method of quantitating organ uptake using a gamma camera. Br J Radiol 54: 1062–1067

    Article  PubMed  CAS  Google Scholar 

  29. Myers MJ, Hooker GR, Epenetos AA (1986) Dosimetry of radiolabelled monoclonal antibodies used for therapy. In: Schlafke-Stelson AT, Watson EE (eds) Fourth International Radio-pharmaceutical Dosimetry Symposium, 5–8 Nov 1985. Oak Ridge Associated Universities, Oak Ridge, Tennessee, pp 409–420

    Google Scholar 

  30. Ward BG, Mather SJ, Shepherd JH (1986) Prospects for antibody targetted radiotherapy of cancer. Lancet 2: 580–581

    Google Scholar 

  31. Malamitsi J, Skarlos D, Fotiou S, Valvaligiou A, Papakostas P, Aravantinos G, Taylor-Papadimitriou J, Epenetos AA, Koutoulidis K (in press). Pharmacokinetics and diagnostic contribution of I 131-labelled HMFG2 monoclonal antibody in pleural and peritoneal metastases from breast and ovarian carcinomas: Advantages of intracavitary administration. J Nucl Med (in press)

    Google Scholar 

  32. Stoscheck CM, King LE (1986) Role of epidermal growth factor in carcinogenesis. Cancer Res 4: 1030–1037

    Google Scholar 

  33. Courtenay-Luck N, Epenetos AA, Moore R, Larche M, Pectasides D, Dhokia B, Ritter MA (1986) Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Cancer Res 46: 6489–6493

    Google Scholar 

  34. Epenetos AA, Snook D, Durbin H, Johnson PM, Taylor-Papadimitriou J (1986) Limitations of radiolabelled monoclonal antibodies for the localisation of human neoplasms. Cancer Res 46: 3181–3191

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Kalofonos, H., Epenetos, A.A. (1989). Radioimmunotherapy with Iodine 131-Labelled Antibodies in Ovarian, Colonic and Brain Tumours. In: Beger, H.G., Büchler, M., Reisfeld, R.A., Schulz, G. (eds) Cancer Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73721-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73721-3_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73723-7

  • Online ISBN: 978-3-642-73721-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics